UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Epilepsia (Copenhagen), ISSN 0013-9580, 08/2013, Volume 54, Issue 4, pp. 44 - 60
Biomarkers | Therapy | Animal models | Comorbidity | Epilepsy | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Drugs, Investigational - adverse effects | Cognition Disorders - chemically induced | Humans | Drugs, Investigational - therapeutic use | Depressive Disorder - drug therapy | Neurocognitive Disorders - psychology | Anxiety Disorders - chemically induced | Migraine Disorders - chemically induced | Neurocognitive Disorders - drug therapy | Depressive Disorder - chemically induced | Quality of Life - psychology | Anxiety Disorders - drug therapy | Drug Evaluation, Preclinical | Cognition Disorders - psychology | Disease Models, Animal | Attention Deficit Disorder with Hyperactivity - chemically induced | Epilepsy - psychology | Translational Medical Research | Neurocognitive Disorders - diagnosis | Neurocognitive Disorders - chemically induced | Cognition Disorders - drug therapy | Anxiety Disorders - psychology | Attention Deficit Disorder with Hyperactivity - drug therapy | Drug Discovery | Migraine Disorders - drug therapy | Epilepsy - diagnosis | Cognition Disorders - diagnosis | Animals | Migraine Disorders - psychology | Attention Deficit Disorder with Hyperactivity - psychology | Epilepsy - drug therapy | Depressive Disorder - psychology | Analysis | Medical research | Quality of life | Index Medicus
Journal Article
CNS drugs, ISSN 1172-7047, 2008, Volume 22, Issue 1, pp. 27 - 47
Migraine | Schizophrenia | Anxiety | Antiepileptic drugs, general | Bipolar disorders | Essential tremor | Neuropathic pain | Pharmacology & Pharmacy | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Mental Disorders - drug therapy | Pain - drug therapy | Humans | Nervous System Diseases - drug therapy | Anticonvulsants - therapeutic use | Anxiety - drug therapy | Nervous System Diseases - physiopathology | Schizophrenia - drug therapy | Essential Tremor - drug therapy | Anticonvulsants - pharmacology | Bipolar Disorder - drug therapy | Migraine Disorders - drug therapy | Drugs | Headache | Drug abuse | Mental disorders | Gabapentin | Epilepsy | Clinical trials | Bipolar disorder | Intracellular signalling | Alcohol | Neuropathy | Antiepileptic agents | Cancer therapies | Fear & phobias | Signal transduction | Pain | Rodents | Human immunodeficiency virus--HIV | Ion channels | Neurological disorders | Calcium channels | Calcium channels (voltage-gated) | Excitability | Etiracetam | Carbamazepine | Asthma | Bulimia | Mood | Post traumatic stress disorder | Anxieties | Cocaine | Glutamatergic transmission | Intracellular | Neurotransmission
Journal Article
Journal of neurology, neurosurgery and psychiatry, ISSN 0022-3050, 03/2019, Volume 90, Issue 3, pp. 353 - 360
sleep | anxiety | fatigue | depression | comorbidities | onabotulinumtoxinA | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Surgery | Science & Technology | Prospective Studies | Drug Administration Schedule | Sleep Wake Disorders - drug therapy | Fatigue - drug therapy | Humans | Depressive Disorder - diagnosis | Anxiety Disorders - diagnosis | Fatigue - etiology | Depressive Disorder - drug therapy | Male | Sleep Wake Disorders - diagnosis | Treatment Outcome | Fatigue - diagnosis | Neuromuscular Agents - therapeutic use | Depressive Disorder - etiology | Anxiety Disorders - etiology | Migraine Disorders - drug therapy | Botulinum Toxins, Type A - therapeutic use | Migraine Disorders - psychology | Adult | Female | Anxiety Disorders - drug therapy | Chronic Disease | Sleep Wake Disorders - etiology | Mental disorders | Comorbidity | Migraine | Feasibility studies | Headaches | Clinical trials | Fatigue | Mental depression | Botulinum toxin | Quality of life | Sleep | Pain | Anxieties | Index Medicus | 1506
Journal Article
European journal of clinical pharmacology, ISSN 0031-6970, 10/2016, Volume 72, Issue 10, pp. 1245 - 1254
Pharmacoepidemiology | Biomedicine | Epilepsy | Norwegian Prescription Database (NorPD) | Non-epilepsy indications | Retention rates | Pharmacovigilance | Pharmacology/Toxicology | Antiepileptic drugs | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Humans | Middle Aged | Anticonvulsants - therapeutic use | Child, Preschool | Infant | Male | Practice Patterns, Physicians | Migraine Disorders - drug therapy | Neuralgia - drug therapy | Young Adult | Medication Adherence | Mental Disorders - drug therapy | Norway | Adolescent | Aged, 80 and over | Adult | Epilepsy - drug therapy | Female | Aged | Child | Drug Utilization - statistics & numerical data | Infant, Newborn | Drugs | Medical research | Anticonvulsants | Pharmacy | Medicine, Experimental | Drug therapy | Studies | Databases | Epidemiology | Index Medicus
Journal Article
Journal of the neurological sciences, ISSN 0022-510X, 2009, Volume 283, Issue 1, pp. 21 - 27
Neurology | Neurological disorders | Central nervous system | Kynurenine pathway | Infectious diseases | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Receptors, Glutamate - metabolism | Brain Diseases - metabolism | Kynurenine - therapeutic use | Humans | Brain Ischemia - metabolism | Epilepsy - metabolism | Parkinson Disease - drug therapy | Neurodegenerative Diseases - drug therapy | Pain - metabolism | Migraine Disorders - metabolism | Brain - metabolism | Brain Diseases - drug therapy | Pain - drug therapy | Parkinson Disease - metabolism | Kynurenine - metabolism | Huntington Disease - drug therapy | Multiple Sclerosis - metabolism | Signal Transduction | Alzheimer Disease - drug therapy | Neurodegenerative Diseases - metabolism | Huntington Disease - metabolism | Migraine Disorders - drug therapy | Animals | Brain Ischemia - drug therapy | Alzheimer Disease - metabolism | Epilepsy - drug therapy | Multiple Sclerosis - drug therapy | Phosphates | Methyl aspartate | Nervous system diseases | Neurosciences | Parkinson's disease | Huntington's chorea | Tryptophan | HIV (Viruses) | Health aspects | Alzheimer's disease | Index Medicus
Journal Article
International journal of molecular sciences, ISSN 1422-0067, 01/2015, Volume 16, Issue 1, pp. 1111 - 1130
schizophrenia | melatonergic receptors | agomelatine | bipolar depression | anxiety | serotonin | alcohol dependence | fibromyalgia | noradrenaline | melatonin | migraines | dopamine | seasonal affective disorder | psychiatric disorders | Seasonal affective disorder | Melatonin | Dopamine | Serotonin | Fibromyalgia | Schizophrenia | Alcohol dependence | Bipolar depression | Migraines | Melatonergic receptors | Agomelatine | Anxiety | Noradrenaline | Psychiatric disorders | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Acetamides - pharmacokinetics | Sleep Wake Disorders - drug therapy | Humans | Receptor, Serotonin, 5-HT2C - metabolism | Depressive Disorder - drug therapy | Bipolar Disorder - drug therapy | Migraine Disorders - drug therapy | Antidepressive Agents - therapeutic use | Acetamides - therapeutic use | Fibromyalgia - drug therapy | Receptor, Serotonin, 5-HT2C - chemistry | Schizophrenia - drug therapy | Antidepressive Agents - pharmacokinetics | Receptor, Melatonin, MT2 - metabolism | Receptor, Melatonin, MT1 - metabolism | Psychological aspects | Antidepressants | Anxieties | Mental depression | Drug use | Index Medicus
Journal Article